Vir Biotechnology
Vir Biotechnology is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 5 tracked investors.
About Vir Biotechnology
Vir Biotechnology is a company founded in 2016 headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 5 investors associated with the company.
Vir Biotechnology is a clinical-stage biotechnology company developing antibody-based medicines and leveraging immune-system-focused technologies, including a next-generation antibody platform and the PRO-XTEN masking technology, to create therapies for infectious diseases and oncology.
Explore Vir Biotechnology's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.